<DOC>
	<DOC>NCT02910765</DOC>
	<brief_summary>effects of methylene blue and ozone O3 therapy effects in early sepsis management , and their implications upon outcome</brief_summary>
	<brief_title>Methylene Blue and Ozone in Early Sepsis</brief_title>
	<detailed_description>effects of methylene blue on inducible nitric oxide messenger RNA transcription and protein expression are well evident in vasoplegia ,and septic shock . In the same time , ozone O3 therapy is also valuable in immune-modulation in multiple pathologies . our study collaborate both methylene blue and Ozone in early sepsis management , and we will evaluate the global medical progress , ICU stay , Morbidity and mortality</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>early sepsis Adults patients cardiac problems Glucose6PhosphateDehydrogenase Insufficiency Ozone Allergy Recent Myocardial Infarction Active Hyperthyroidism Thrombocytopenia Pregnancy Contraindications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>